Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return

Bliss GVS Pharma, a small-cap player in the pharmaceuticals and drugs industry, has recently reached a new 52-week high of Rs. 181.35 on January 1, 2025. The stock has shown strong performance, outperforming its sector by 7.79% today. Over the past six days, Bliss GVS Pharma has experienced consecutive gains, accumulating a total return of 11.29%.

The stock’s intraday high of Rs. 181.35 reflects a 10.14% increase for the day. Additionally, Bliss GVS Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.

In terms of annual performance, Bliss GVS Pharma has delivered a notable return of 42.53% over the past year, significantly outpacing the Sensex, which has recorded an 8.20% increase during the same period. The stock’s recent performance highlights its resilience and growth within the competitive pharmaceuticals sector.

Related Posts

  • Pharma
  • July 8, 2025
  • 33 views
‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

As it turns 3, New American Kid on the Block strikes gold Delhi NCR:  AACI (American Accreditation Commission International) took such giant strides in India in just three years as…

  • Pharma
  • July 5, 2025
  • 208 views
Traditional medicine crucial to achieving global goals of Universal Health Coverage

Global goals like Universal Health Coverage (UHC) can only be met when traditional medicine becomes an essential part of the national health policy and wellness delivery, said Dr. Kashinath Samagandi,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

‘AACI Came, AACI Saw, AACI Conquered’ Indian Accreditation Domain in Healthcare

Traditional medicine crucial to achieving global goals of Universal Health Coverage

Traditional medicine crucial to achieving global goals of Universal Health Coverage

Lupin launches Ipratropium Bromide nasal spray in US

Lupin launches Ipratropium Bromide nasal spray in US

Surgical Robot MantraM, First ‘Badge of Vishwaguru’ is on Triumphal March

Surgical Robot MantraM, First ‘Badge of Vishwaguru’ is on Triumphal March